Overseas Pharmaceutical

Retatrutide is a triple hormone receptor agonist that mimics the actions of GLP-1, GIP, and glucagon, and is being studied for its potential in weight loss and metabolic health. Specifically, a 5mg vial of retatrutide is available for research purposes. It is a peptide that targets these three receptors, which is thought to promote weight loss by enhancing insulin release, dissolving fats, suppressing appetite, and lowering blood sugar levels.